Results 191 to 200 of about 75,376 (234)

Soma Ca²⁺ is decoupled from daily synaptic activity and neuropeptide release in Drosophila clock neurons. [PDF]

Curr Biol
Klose MK, Kim J, Gregg SN, Schmidt BF, Xia X, Li Y, Levitan ES.   +6 more
europepmc   +1 more source

Identification of a G Protein-Coupled Receptor for Buccalin-Type Peptides in the Mollusk <i>Aplysia</i>: Evolutionary Insights into Neuropeptide Signaling. [PDF]

ACS Omega
Xu JP, Ding XY, Jin QC, Zhang YL, Chang JH, Jiang HM, Li YD, Fu P, Zhang YC, Liu CP, Mao RT, Liu CY, Li F, Wu SQ, Cropper EC, Zhang G, Jing J.   +16 more
europepmc   +1 more source

Neuropeptide Y1 receptor expressing circuit from the central amygdala to lateral hypothalamus modulates binge-like ethanol consumption in a sex-dependent manner. [PDF]

Alcohol Clin Exp Res (Hoboken)
Bendrath SC, Stone A, Dankert AM, Thiele TE.   +3 more
europepmc   +1 more source

Significance of neuroendocrine systems and the gut-brain axis (GBA) in the regulation of obesity. [PDF]

PeerJ
Zhao H, Li Y, Cheng R, Wang Y, Ma L, Chen W.   +5 more
europepmc   +1 more source

Peptidergic Systems and Neuroblastoma. [PDF]

Int J Mol Sci
Sánchez ML, Coveñas R.
europepmc   +1 more source

Role of the bed nucleus of the stria terminalis in feeding. [PDF]

Front Nutr
Wang K, Guo W, Xu J, Kuang Y, Chen X.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Neuropeptide Y receptor subtypes

Life Sciences, 1995
Neuropeptide Y (NPY) is an amidated 36-amino acid peptide with a wide distribution in the central and peripheral nervous system. It can evoke numerous physiological responses by activating specific receptors. Studies using NPY analogs in various model systems and cell types demonstrate different orders of ligand potency and receptor binding affinity ...
C P, Wan, B H, Lau
openaire   +2 more sources

Dihydropyridine Neuropeptide Y Y1 Receptor Antagonists

Bioorganic & Medicinal Chemistry Letters, 2002
Dihydropyridine 5a was found to be an inhibitor of neuropeptide Y(1) binding in a high throughput (125)I-PYY screening assay. Structure-activity studies around certain portions of the dihydropyridine chemotype identified BMS-193885 (6e) as a potent and selective Y(1) receptor antagonist.
Graham S, Poindexter, Marc A, Bruce, Karen L, LeBoulluec, Ivo, Monkovic, Scott W, Martin, Eric M, Parker, Larry G, Iben, Rachel T, McGovern, Astrid A, Ortiz, Jennifer A, Stanley, Gail K, Mattson, Michael, Kozlowski, Meredith, Arcuri, Ildiko, Antal-Zimanyi   +13 more
openaire   +2 more sources